Join
Live feed
·
INSIDERFilingvia Quantisnow
Avenue Therapeutics Inc. logo

Director Kranzler Jay D bought $1,250 worth of shares (500 units at $2.50), increasing direct ownership by 417% to 620 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATXI· Avenue Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXI (Avenue Therapeutics Inc.) and more on Quantisnow.